WEAV Earnings

WEAV reported its earnings on 2026-02-19, showcasing a revenue of 63.40M against an estimate of 63.08M, resulting in a 0.51% surprise. The EPS was 0.03, surpassing the expected 0.03 by 0%. The stock experienced a -4.91% price change on the earnings day and a -14.04% change over the next five days, reflecting market reactions to the results.

Following WEAV's earnings announcement on 2026-02-19, the stock price moved by -4.91% on the day of the release. Over the subsequent five days, it saw a -14.04% change. Historically, WEAV's stock price tends to shift by an average of 0.68% in the 10 days leading up to earnings and -2.43% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate WEAV's annual revenue to reach 64.67M, while the EPS is projected at 0.02. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between WEAV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, WEAV's stock price typically moves by 0.68% in the 10 days before its earnings and -2.43% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.02 and revenue of 64.67M.

The earnings call reveals strong revenue growth, improved gross margins, and increased free cash flow, suggesting financial strength. The company is raising its revenue and operating income guidance, indicating confidence in future performance. Expansion in AI and specialty medical verticals, alongside a new CareCredit partnership, further supports growth prospects. Despite some uncertainties in growth rates and product impacts, the overall sentiment is positive due to strategic initiatives and financial improvements.